NEW YORK – Water filtration and pathogen detection company Nephros said on Monday that it has acquired substantially all of the assets of infectious disease monitoring firm GenArraytion.
Terms of the acquisition were not disclosed.
Nephros said the deal will give it access to GenArraytion's proprietary assays, multiplexing technology, and selection methods for detecting waterborne pathogens and other microorganisms using PCR technology. GenArraytion's assets will be integrated into the Nephros Pathogen Detection Systems platform.
"The strategic acquisition of GenArraytion further cements our position in the emerging PCR testing market for waterborne pathogens, expanding our abilities to detect and mitigate the spread of infectious disease in premise plumbing," Nephros CEO Andy Astor said in a statement. "Working together, our unified organization will provide customers the ability to use on-site testing with fast, accurate, and actionable data as part of their water management programs."